Metropolitan Life Insurance Company (MetLife)’s Duck Creek Technologies, Inc. Common Stock DCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,667
Closed -$56.2K 2511
2022
Q4
$56.2K Hold
4,667
﹤0.01% 1401
2022
Q3
$55.3K Hold
4,667
﹤0.01% 1401
2022
Q2
$69.3K Buy
+4,667
New +$82K ﹤0.01% 1300
2022
Q1
Sell
-2,174
Closed -$65.5K 2769
2021
Q4
$65.5K Sell
2,174
-5
-0.2% -$161 ﹤0.01% 2662
2021
Q3
$96.4K Sell
2,179
-80
-4% -$3.62K ﹤0.01% 2541
2021
Q2
$98.3K Sell
2,259
-2,362
-51% -$96.1K ﹤0.01% 2596
2021
Q1
$209K Buy
4,621
+3,113
+206% +$150K ﹤0.01% 1992
2020
Q4
$65.3K Buy
1,508
+541
+56% +$22.9K ﹤0.01% 2451
2020
Q3
$43.9K Buy
+967
New +$39K ﹤0.01% 2478

Other funds holding DCT

Metropolitan Life Insurance Company (MetLife)'s DCT Position: Q1 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Duck Creek Technologies, Inc. Common Stock (DCT) in Q1 2023, closing a stake of 4,667 shares — an estimated $56.2K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in DCT in Q3 2020 and held it in 9 quarters. The position peaked at $209K in Q1 2021. 4 funds tracked by Wall St. Rank hold DCT as of Q1 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Duck Creek Technologies, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 4,667 Duck Creek Technologies, Inc. Common Stock shares in Q1 2023, an estimated $56.2K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Duck Creek Technologies, Inc. Common Stock in Q3 2020 and held it in 9 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Duck Creek Technologies, Inc. Common Stock position peaked at $209K in Q1 2021.
  • 4 funds tracked by Wall St. Rank held Duck Creek Technologies, Inc. Common Stock as of Q1 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2023, filed 15 May 2023.